Advertisement

US Aims to Help More Cancer Patients Try Experimental Drugs

MARILYNN MARCHIONE, AP Chief Medical Writer
Created: June 03, 2019 06:02 PM

CHICAGO (AP) - U.S. drug regulators are launching a project aimed at giving more cancer patients a chance to try treatments that are not yet on the market but that have shown some promise in early testing.

Advertisement – Content Continues Below

Currently, when patients want what's called "compassionate use" access to an experimental drug, doctors must first plead their case to the drug company and then to the Food and Drug Administration if the company agrees.

Under the new plan, the FDA becomes the first stop and will assign someone to do the paperwork, so that when a drug company gets the request it knows the FDA already deemed it appropriate.

FDA officials say they can't force companies to provide access but hope that more will. The plan was announced Monday at a cancer conference in Chicago.

Credits

MARILYNN MARCHIONE, AP Chief Medical Writer

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement

Tower City Council Votes to Suspend City Clerk with Pay

Conway Carries On: Deceased Runner Receives Ambassador Award

Rep. Stauber Meets with Officials to Discuss Opioid Crisis, Rural Healthcare

Family of World War II Veteran Presented High Honor

US to Send More Troops to Middle East

National Gathering in Twin Ports on Philanthropy's Role in Disaster Recovery

Advertisement